These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 8360632)

  • 21. Group-specific serum antibody responses in children with primary and recurrent respiratory syncytial virus infections.
    Muelenaer PM; Henderson FW; Hemming VG; Walsh EE; Anderson LJ; Prince GA; Murphy BR
    J Infect Dis; 1991 Jul; 164(1):15-21. PubMed ID: 2056202
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Synthetic peptides corresponding to the F protein of RSV stimulate murine B and T cells but fail to confer protection.
    Trudel M; Stott EJ; Taylor G; Oth D; Mercier G; Nadon F; Séguin C; Simard C; Lacroix M
    Arch Virol; 1991; 117(1-2):59-71. PubMed ID: 1706591
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Subgroup characteristics of respiratory syncytial virus strains recovered from children with two consecutive infections.
    Mufson MA; Belshe RB; Orvell C; Norrby E
    J Clin Microbiol; 1987 Aug; 25(8):1535-9. PubMed ID: 3305568
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Analysis of linear epitopes recognised by the primary human antibody response to a variable region of the attachment (G) protein of respiratory syncytial virus.
    Cane PA
    J Med Virol; 1997 Apr; 51(4):297-304. PubMed ID: 9093944
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Effect of passive antibody on the immune response of cotton rats to purified F and G glycoproteins of respiratory syncytial virus (RSV).
    Murphy BR; Prince GA; Collins PL; Hildreth SW; Paradiso PR
    Vaccine; 1991 Mar; 9(3):185-9. PubMed ID: 2042390
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Effect of age and preexisting antibody on serum antibody response of infants and children to the F and G glycoproteins during respiratory syncytial virus infection.
    Murphy BR; Alling DW; Snyder MH; Walsh EE; Prince GA; Chanock RM; Hemming VG; Rodriguez WJ; Kim HW; Graham BS
    J Clin Microbiol; 1986 Nov; 24(5):894-8. PubMed ID: 3771779
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Respiratory syncytial virus (RSV) SH and G proteins are not essential for viral replication in vitro: clinical evaluation and molecular characterization of a cold-passaged, attenuated RSV subgroup B mutant.
    Karron RA; Buonagurio DA; Georgiu AF; Whitehead SS; Adamus JE; Clements-Mann ML; Harris DO; Randolph VB; Udem SA; Murphy BR; Sidhu MS
    Proc Natl Acad Sci U S A; 1997 Dec; 94(25):13961-6. PubMed ID: 9391135
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Polylactosaminoglycan modification of the respiratory syncytial virus small hydrophobic (SH) protein: a conserved feature among human and bovine respiratory syncytial viruses.
    Anderson K; King AM; Lerch RA; Wertz GW
    Virology; 1992 Nov; 191(1):417-30. PubMed ID: 1413513
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Antibody response to respiratory syncytial virus structural proteins in children with acute respiratory syncytial virus infection.
    Vainionpää R; Meurman O; Sarkkinen H
    J Virol; 1985 Mar; 53(3):976-9. PubMed ID: 3973971
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Serum immunoglobulin G antibody subclass response to respiratory syncytial virus F and G glycoproteins after first, second, and third infections.
    Wagner DK; Muelenaer P; Henderson FW; Snyder MH; Reimer CB; Walsh EE; Anderson LJ; Nelson DL; Murphy BR
    J Clin Microbiol; 1989 Mar; 27(3):589-92. PubMed ID: 2715331
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Vaccination with a heterologous respiratory syncytial virus chimeric FG glycoprotein demonstrates significant subgroup cross-reactivity.
    Oien NL; Brideau RJ; Thomsen DR; Homa FL; Wathen MW
    Vaccine; 1993; 11(10):1040-8. PubMed ID: 8212825
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The response of infants with bronchiolitis to the proteins of respiratory syncytial virus.
    Levine S; Dajani A; Klaiber-Franco R
    J Gen Virol; 1988 Jun; 69 ( Pt 6)():1229-39. PubMed ID: 3385405
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Detection of antibodies to respiratory syncytial virus attachment and nucleocapsid proteins with recombinant baculovirus-expressed antigens.
    Buraphacheep W; Britt WJ; Sullender WM
    J Clin Microbiol; 1997 Feb; 35(2):354-7. PubMed ID: 9003595
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Antibodies to respiratory syncytial virus polypeptides and their significance in human infection.
    Ward KA; Lambden PR; Ogilvie MM; Watt PJ
    J Gen Virol; 1983 Sep; 64 (Pt 9)():1867-76. PubMed ID: 6886679
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Characterization of two antigenic sites recognized by neutralizing monoclonal antibodies directed against the fusion glycoprotein of human respiratory syncytial virus.
    Arbiza J; Taylor G; López JA; Furze J; Wyld S; Whyte P; Stott EJ; Wertz G; Sullender W; Trudel M
    J Gen Virol; 1992 Sep; 73 ( Pt 9)():2225-34. PubMed ID: 1383404
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Cross-reactive and group-specific immune responses to a neutralizing epitope of the human respiratory syncytial virus fusion protein.
    Corvaisier C; Bourgeois C; Pothier P
    Arch Virol; 1997; 142(6):1073-86. PubMed ID: 9228999
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Linear antigenic and immunogenic regions of the respiratory syncytial virus P protein.
    Leonov SV; Utter G; Waris M; Norrby E
    J Gen Virol; 1994 Jun; 75 ( Pt 6)():1353-9. PubMed ID: 8207401
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Relationship of serum antibody to risk of respiratory syncytial virus infection in elderly adults.
    Falsey AR; Walsh EE
    J Infect Dis; 1998 Feb; 177(2):463-6. PubMed ID: 9466538
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Use of synthetic peptides to locate neutralizing antigenic domains on the fusion protein of respiratory syncytial virus.
    Bourgeois C; Corvaisier C; Bour JB; Kohli E; Pothier P
    J Gen Virol; 1991 May; 72 ( Pt 5)():1051-8. PubMed ID: 2033389
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Location of the epitope recognized by monoclonal antibody 63G on the primary structure of human respiratory syncytial virus G glycoprotein and the ability of synthetic peptides containing this epitope to induce neutralizing antibodies.
    Garcia-Barreno B; Delgado T; Akerlind-Stopner B; Norrby E; Melero JA
    J Gen Virol; 1992 Oct; 73 ( Pt 10)():2625-30. PubMed ID: 1383397
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.